Potential factors of false-negative sentinel lymph node biopsy for breast cancer and clinical decision-making value of axillary lymph node dissection
Tumor size, vascular invasion, and the number of SLNs detected were independent risk factors for false negatives in SLNB for breast cancer. The risk scoring system could complement the trial protocols such as ACOSOGZ0011 and AMAROS. This provided quantifiable tools for clinical decision-making.
Authors
- Meng Dong (ORCID: https://orcid.org/0000-0001-9622-1737)
- Jin Li (ORCID: https://orcid.org/0000-0001-8526-4395)
Institutions
- Jiangnan University (CN)
Publication Details
- Journal
- BMC Surgery
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1186/s12893-025-03283-z
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00